FDA clears Zanvastro (zilganersen) as the first disease-modifying therapy for Alexander disease following positive Phase 1-3 trial results.

Mounjaro approval expanded to reduce the risk of major cardiovascular events; The American Academy of Pediatrics has issued updated recommendations for RSV immunization; BTK inhibitor shows promise in ...

Blood-based test identifies presence of amyloid plaques in symptomatic adults and is intended to be used in conjunction with a clinical assessment ...

The updated guidelines broaden the high-risk criteria for children aged 8 to 19 months entering their second RSV season.

Following Fast Track designation, a phase 2a trial will evaluate inhaled treprostinil (Yutrepia) as a potential first-in-class therapy for Raynaud phenomenon in systemic sclerosis.

HealthDay News — Silent atherosclerosis is detectable in early adulthood and increases with age, according to a study published online August 29 in the New England Journal of Medicine to coincide with ...

HealthDay News — Time-restricted eating (TRE) may help adults with type 1 diabetes (T1D) and overweight control their blood sugar, according to a study published online August 17 in Diabetes Care.

Lisraya is the first oral dual TYK2/JAK1 inhibitor indicated for adults with dermatomyositis, demonstrating significant ...

FDA approves updated 2026-2027 COVID-19 vaccine formulations targeting the XFG variant for older adults and high-risk ...

Updated recommendations are presented to help clinicians decide which medications may be effective for preventing migraine in adults in 2 reports issued by the American Academy of Neurology and ...

HealthDay News — Paternal exposure to valproate during sperm development is not associated with neurodevelopmental disorders (NDDs) in offspring, according to a study published online August 19 in ...

Proportion of women never screened for cervical cancer increased, with more pronounced increase from 2010 to 2023 ...